article-journal | icostatistics https://icostatistics.no/publication-type/article-journal/ article-journal Hugo Blox Builder (https://hugoblox.com)en-usWed, 01 Nov 2023 00:00:00 +0000 https://icostatistics.no/media/icon_hu0b7a4cb9992c9ac0e91bd28ffd38dd00_9727_512x512_fill_lanczos_center_3.png article-journal https://icostatistics.no/publication-type/article-journal/ Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial https://icostatistics.no/publication/lillegraven-effect-2023/ Wed, 01 Nov 2023 00:00:00 +0000 https://icostatistics.no/publication/lillegraven-effect-2023/ Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial https://icostatistics.no/publication/ostergaard-certolizumab-2023/ Sun, 01 Oct 2023 00:00:00 +0000 https://icostatistics.no/publication/ostergaard-certolizumab-2023/ The international Unity study for antivirals against mpox is a blueprint for future epidemics https://icostatistics.no/publication/telford-international-2023/ Tue, 01 Aug 2023 00:00:00 +0000 https://icostatistics.no/publication/telford-international-2023/ Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials https://icostatistics.no/publication/amstutz-effects-2023/ Mon, 01 May 2023 00:00:00 +0000 https://icostatistics.no/publication/amstutz-effects-2023/ Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia https://icostatistics.no/publication/terzic-implementation-2023/ Sat, 01 Apr 2023 00:00:00 +0000 https://icostatistics.no/publication/terzic-implementation-2023/ Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden https://icostatistics.no/publication/heggebo-investigating-2023/ Wed, 01 Mar 2023 00:00:00 +0000 https://icostatistics.no/publication/heggebo-investigating-2023/ Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial https://icostatistics.no/publication/troseid-efficacy-2023/ Sun, 01 Jan 2023 00:00:00 +0000 https://icostatistics.no/publication/troseid-efficacy-2023/ Immunocompromised patients have been neglected in COVID-19 trials: a call for action https://icostatistics.no/publication/troseid-immunocompromised-2022/ Thu, 01 Sep 2022 00:00:00 +0000 https://icostatistics.no/publication/troseid-immunocompromised-2022/ Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial https://icostatistics.no/publication/brun-risk-2022/ Thu, 01 Sep 2022 00:00:00 +0000 https://icostatistics.no/publication/brun-risk-2022/ Early food intervention and skin emollients to prevent food allergy in young children (PreventADALL): a factorial, multicentre, cluster-randomised trial https://icostatistics.no/publication/skjerven-early-2022/ Wed, 01 Jun 2022 00:00:00 +0000 https://icostatistics.no/publication/skjerven-early-2022/ Respiratory dysfunction three months after severe COVID-19 is associated with gut microbiota alterations https://icostatistics.no/publication/vestad-respiratory-2022/ Wed, 01 Jun 2022 00:00:00 +0000 https://icostatistics.no/publication/vestad-respiratory-2022/ Neutrophil count predicts clinical outcome in hospitalized COVID-19 patients: Results from the NOR-Solidarity trial https://icostatistics.no/publication/kasine-neutrophil-2022/ Tue, 01 Feb 2022 00:00:00 +0000 https://icostatistics.no/publication/kasine-neutrophil-2022/ Accelerating clinical trial implementation in the context of the COVID-19 pandemic: challenges, lessons learned and recommendations from DisCoVeRy and the EU-SolidAct EU response group https://icostatistics.no/publication/eu-response-investigators-group-accelerating-2022/ Sat, 01 Jan 2022 00:00:00 +0000 https://icostatistics.no/publication/eu-response-investigators-group-accelerating-2022/ Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial https://icostatistics.no/publication/syversen-effect-2021/ Wed, 01 Dec 2021 00:00:00 +0000 https://icostatistics.no/publication/syversen-effect-2021/ Persistent pulmonary pathology after COVID-19 is associated with high viral load, weak antibody response, and high levels of matrix metalloproteinase-9 https://icostatistics.no/publication/lerum-persistent-2021/ Wed, 01 Dec 2021 00:00:00 +0000 https://icostatistics.no/publication/lerum-persistent-2021/ A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients https://icostatistics.no/publication/jenum-phase-2021/ Mon, 01 Nov 2021 00:00:00 +0000 https://icostatistics.no/publication/jenum-phase-2021/ Joint tenderness and ultrasound inflammation in DMARD-naïve patients with early rheumatoid arthritis https://icostatistics.no/publication/paulshus-sundlisater-joint-2021/ Mon, 01 Nov 2021 00:00:00 +0000 https://icostatistics.no/publication/paulshus-sundlisater-joint-2021/ Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19 : A Randomized Trial https://icostatistics.no/publication/barratt-due-evaluation-2021/ Wed, 01 Sep 2021 00:00:00 +0000 https://icostatistics.no/publication/barratt-due-evaluation-2021/ Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial https://icostatistics.no/publication/lillegraven-effect-2021/ Sat, 01 May 2021 00:00:00 +0000 https://icostatistics.no/publication/lillegraven-effect-2021/ Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial https://icostatistics.no/publication/syversen-effect-2021-1/ Sat, 01 May 2021 00:00:00 +0000 https://icostatistics.no/publication/syversen-effect-2021-1/ EU-SolidAct https://icostatistics.no/publication/olsen-eu-solidact-2021/ Mon, 01 Feb 2021 00:00:00 +0000 https://icostatistics.no/publication/olsen-eu-solidact-2021/ Active conventional treatment and three different biological treatments in early rheumatoid arthritis: phase IV investigator initiated, randomised, observer blinded clinical trial https://icostatistics.no/publication/hetland-active-2020/ Tue, 01 Dec 2020 00:00:00 +0000 https://icostatistics.no/publication/hetland-active-2020/ A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics https://icostatistics.no/publication/lyngbakken-pragmatic-2020/ Thu, 01 Oct 2020 00:00:00 +0000 https://icostatistics.no/publication/lyngbakken-pragmatic-2020/ Efficacy and Safety of CT-P13 in Inflammatory Bowel Disease after Switching from Originator Infliximab: Exploratory Analyses from the NOR-SWITCH Main and Extension Trials https://icostatistics.no/publication/jorgensen-efficacy-2020/ Thu, 01 Oct 2020 00:00:00 +0000 https://icostatistics.no/publication/jorgensen-efficacy-2020/ Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial https://icostatistics.no/publication/lyngbakken-norwegian-2020/ Mon, 01 Jun 2020 00:00:00 +0000 https://icostatistics.no/publication/lyngbakken-norwegian-2020/ Opportunistic treatment of hepatitis C virus infection (OPPORTUNI-C): study protocol for a pragmatic stepped wedge cluster randomized trial of immediate versus outpatient treatment initiation among hospitalized people who inject drugs https://icostatistics.no/publication/midgard-opportunistic-2020/ Mon, 01 Jun 2020 00:00:00 +0000 https://icostatistics.no/publication/midgard-opportunistic-2020/ Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial https://icostatistics.no/publication/skjerven-skin-2020/ Sun, 01 Mar 2020 00:00:00 +0000 https://icostatistics.no/publication/skjerven-skin-2020/ The Labour Progression Study (LaPS): Duration of labour following Zhang's guideline and the WHO partograph - A cluster randomised trial https://icostatistics.no/publication/dalbye-labour-2020/ Sat, 01 Feb 2020 00:00:00 +0000 https://icostatistics.no/publication/dalbye-labour-2020/ Therapeutic drug monitoring of infliximab compared to standard clinical treatment with infliximab: study protocol for a randomised, controlled, open, parallel-group, phase IV study (the NOR-DRUM study) https://icostatistics.no/publication/syversen-therapeutic-2020/ Wed, 01 Jan 2020 00:00:00 +0000 https://icostatistics.no/publication/syversen-therapeutic-2020/ Comment on: Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry: reply https://icostatistics.no/publication/olsen-comment-2019/ Tue, 01 Oct 2019 00:00:00 +0000 https://icostatistics.no/publication/olsen-comment-2019/ The Labor Progression Study: The use of oxytocin augmentation during labor following Zhang's guideline and the WHO partograph in a cluster randomized trial https://icostatistics.no/publication/dalbye-labor-2019/ Sun, 01 Sep 2019 00:00:00 +0000 https://icostatistics.no/publication/dalbye-labor-2019/ Zhang's guidelines vs WHO guidelines for diagnosing labour dystocia - Authors' reply https://icostatistics.no/publication/bernitz-zhangs-2019/ Thu, 01 Aug 2019 00:00:00 +0000 https://icostatistics.no/publication/bernitz-zhangs-2019/ Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial https://icostatistics.no/publication/goll-long-term-2019/ Sat, 01 Jun 2019 00:00:00 +0000 https://icostatistics.no/publication/goll-long-term-2019/ Assessments of the unmet need in the management of patients with rheumatoid arthritis: analyses from the NOR-DMARD registry https://icostatistics.no/publication/olsen-assessments-2019/ Fri, 01 Mar 2019 00:00:00 +0000 https://icostatistics.no/publication/olsen-assessments-2019/ Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases https://icostatistics.no/publication/ikdahl-guideline-2019/ Tue, 01 Jan 2019 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-guideline-2019/ The frequency of intrapartum caesarean section use with the WHO partograph versus Zhang's guideline in the Labour Progression Study (LaPS): a multicentre, cluster-randomised controlled trial https://icostatistics.no/publication/bernitz-frequency-2019/ Tue, 01 Jan 2019 00:00:00 +0000 https://icostatistics.no/publication/bernitz-frequency-2019/ Predictors of sustained remission in patients with early rheumatoid arthritis treated according to an aggressive treat-to-target protocol https://icostatistics.no/publication/paulshus-sundlisaeter-predictors-2018/ Thu, 01 Nov 2018 00:00:00 +0000 https://icostatistics.no/publication/paulshus-sundlisaeter-predictors-2018/ Clinical and ultrasound remission after 6 months of treat-to-target therapy in early rheumatoid arthritis: associations to future good radiographic and physical outcomes https://icostatistics.no/publication/paulshus-sundlisaeter-clinical-2018/ Mon, 01 Oct 2018 00:00:00 +0000 https://icostatistics.no/publication/paulshus-sundlisaeter-clinical-2018/ The Impact of Ultrasound on the Use and Efficacy of Intraarticular Glucocorticoid Injections in Early Rheumatoid Arthritis: Secondary Analyses From a Randomized Trial Examining the Benefit of Ultrasound in a Clinical Tight Control Regimen https://icostatistics.no/publication/nordberg-impact-2018/ Wed, 01 Aug 2018 00:00:00 +0000 https://icostatistics.no/publication/nordberg-impact-2018/ Ibuprofen versus pivmecillinam for uncomplicated urinary tract infection in women-A double-blind, randomized non-inferiority trial https://icostatistics.no/publication/vik-ibuprofen-2018/ Tue, 01 May 2018 00:00:00 +0000 https://icostatistics.no/publication/vik-ibuprofen-2018/ Discrepancies in risk age and relative risk estimations of cardiovascular disease in patients with inflammatory joint diseases https://icostatistics.no/publication/wibetoe-discrepancies-2018/ Thu, 01 Feb 2018 00:00:00 +0000 https://icostatistics.no/publication/wibetoe-discrepancies-2018/ Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial https://icostatistics.no/publication/nordberg-comparing-2018/ Mon, 01 Jan 2018 00:00:00 +0000 https://icostatistics.no/publication/nordberg-comparing-2018/ Feasibility of cardiovascular disease risk assessments in rheumatology outpatient clinics: experiences from the nationwide NOCAR project https://icostatistics.no/publication/ikdahl-feasibility-2018/ Mon, 01 Jan 2018 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-feasibility-2018/ Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study https://icostatistics.no/publication/norvang-predicting-2018/ Mon, 01 Jan 2018 00:00:00 +0000 https://icostatistics.no/publication/norvang-predicting-2018/ Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis https://icostatistics.no/publication/jonsson-calprotectin-2017/ Fri, 01 Dec 2017 00:00:00 +0000 https://icostatistics.no/publication/jonsson-calprotectin-2017/ Efficacy of infliximab biosimilars in patients with Crohn's disease - Authors' reply https://icostatistics.no/publication/jorgensen-efficacy-2017/ Fri, 01 Dec 2017 00:00:00 +0000 https://icostatistics.no/publication/jorgensen-efficacy-2017/ Tumour necrosis factor inhibitor treatment and occurrence of anterior uveitis in ankylosing spondylitis: results from the Swedish biologics register https://icostatistics.no/publication/lie-tumour-2017/ Fri, 01 Sep 2017 00:00:00 +0000 https://icostatistics.no/publication/lie-tumour-2017/ Cardiovascular disease risk profiles in inflammatory joint disease entities https://icostatistics.no/publication/wibetoe-cardiovascular-2017/ Sat, 01 Jul 2017 00:00:00 +0000 https://icostatistics.no/publication/wibetoe-cardiovascular-2017/ Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial https://icostatistics.no/publication/jorgensen-switching-2017/ Thu, 01 Jun 2017 00:00:00 +0000 https://icostatistics.no/publication/jorgensen-switching-2017/ Sleep disturbance in patients with rheumatoid arthritis is related to fatigue, disease activity, and other patient-reported outcomes https://icostatistics.no/publication/austad-sleep-2017/ Wed, 01 Mar 2017 00:00:00 +0000 https://icostatistics.no/publication/austad-sleep-2017/ Calcium supplementation and inflammation increase mortality in rheumatoid arthritis: A 15-year cohort study in 609 patients from the Oslo Rheumatoid Arthritis Register https://icostatistics.no/publication/provan-calcium-2017/ Wed, 01 Feb 2017 00:00:00 +0000 https://icostatistics.no/publication/provan-calcium-2017/ Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria https://icostatistics.no/publication/nordberg-patients-2017/ Wed, 01 Feb 2017 00:00:00 +0000 https://icostatistics.no/publication/nordberg-patients-2017/ 4β-Hydroxycholesterol Level in Patients With Rheumatoid Arthritis Before vs. After Initiation of bDMARDs and Correlation With Inflammatory State https://icostatistics.no/publication/wollmann-4-hydroxycholesterol-2017/ Sun, 01 Jan 2017 00:00:00 +0000 https://icostatistics.no/publication/wollmann-4-hydroxycholesterol-2017/ Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases https://icostatistics.no/publication/semb-exploring-2016/ Tue, 01 Nov 2016 00:00:00 +0000 https://icostatistics.no/publication/semb-exploring-2016/ The association of hypertension with asymptomatic cardiovascular organ damage in rheumatoid arthritis https://icostatistics.no/publication/midtbo-association-2016/ Sat, 01 Oct 2016 00:00:00 +0000 https://icostatistics.no/publication/midtbo-association-2016/ Predictive Value of Arterial Stiffness and Subclinical Carotid Atherosclerosis for Cardiovascular Disease in Patients with Rheumatoid Arthritis https://icostatistics.no/publication/ikdahl-predictive-2016/ Thu, 01 Sep 2016 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-predictive-2016/ First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach https://icostatistics.no/publication/aga-first-2016/ Mon, 01 Aug 2016 00:00:00 +0000 https://icostatistics.no/publication/aga-first-2016/ Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial https://icostatistics.no/publication/haavardsholm-ultrasound-2016/ Mon, 01 Aug 2016 00:00:00 +0000 https://icostatistics.no/publication/haavardsholm-ultrasound-2016/ Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study https://icostatistics.no/publication/uhlig-achievement-2016/ Fri, 01 Apr 2016 00:00:00 +0000 https://icostatistics.no/publication/uhlig-achievement-2016/ Effectiveness of an Integrated Multidisciplinary Osteoarthritis Outpatient Program versus Outpatient Clinic as Usual: A Randomized Controlled Trial https://icostatistics.no/publication/moe-effectiveness-2016/ Mon, 01 Feb 2016 00:00:00 +0000 https://icostatistics.no/publication/moe-effectiveness-2016/ Involvement of the multidisciplinary team and outcomes in inpatient rehabilitation among patients with inflammatory rheumatic disease https://icostatistics.no/publication/uhlig-involvement-2016/ Fri, 01 Jan 2016 00:00:00 +0000 https://icostatistics.no/publication/uhlig-involvement-2016/ Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study https://icostatistics.no/publication/ikdahl-sustained-2016/ Fri, 01 Jan 2016 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-sustained-2016/ Rosuvastatin improves endothelial function in patients with inflammatory joint diseases, longitudinal associations with atherosclerosis and arteriosclerosis: results from the RORA-AS statin intervention study https://icostatistics.no/publication/ikdahl-rosuvastatin-2015/ Thu, 01 Oct 2015 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-rosuvastatin-2015/ CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up https://icostatistics.no/publication/berg-crp-2015/ Sat, 01 Aug 2015 00:00:00 +0000 https://icostatistics.no/publication/berg-crp-2015/ Rosuvastatin-Induced Carotid Plaque Regression in Patients With Inflammatory Joint Diseases: The Rosuvastatin in Rheumatoid Arthritis, Ankylosing Spondylitis and Other Inflammatory Joint Diseases Study https://icostatistics.no/publication/rollefstad-rosuvastatin-induced-2015/ Wed, 01 Jul 2015 00:00:00 +0000 https://icostatistics.no/publication/rollefstad-rosuvastatin-induced-2015/ Disease activity in ankylosing spondylitis and associations to markers of vascular pathology and traditional cardiovascular disease risk factors: a cross-sectional study https://icostatistics.no/publication/berg-disease-2015/ Wed, 01 Apr 2015 00:00:00 +0000 https://icostatistics.no/publication/berg-disease-2015/ Genetic risk scores and number of autoantibodies in patients with rheumatoid arthritis https://icostatistics.no/publication/maehlen-genetic-2015/ Wed, 01 Apr 2015 00:00:00 +0000 https://icostatistics.no/publication/maehlen-genetic-2015/ Disease activity and left ventricular structure in patients with rheumatoid arthritis https://icostatistics.no/publication/midtbo-disease-2015/ Sun, 01 Mar 2015 00:00:00 +0000 https://icostatistics.no/publication/midtbo-disease-2015/ Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010 https://icostatistics.no/publication/aga-time-2015/ Sun, 01 Feb 2015 00:00:00 +0000 https://icostatistics.no/publication/aga-time-2015/ Circulating levels of inflammatory cytokines and cytokine receptors in patients with ankylosing spondylitis: a cross-sectional comparative study https://icostatistics.no/publication/sveaas-circulating-2015/ Thu, 01 Jan 2015 00:00:00 +0000 https://icostatistics.no/publication/sveaas-circulating-2015/ EULAR task force recommendations on annual cardiovascular risk assessment for patients with rheumatoid arthritis: an audit of the success of implementation in a rheumatology outpatient clinic https://icostatistics.no/publication/ikdahl-eular-2015/ Thu, 01 Jan 2015 00:00:00 +0000 https://icostatistics.no/publication/ikdahl-eular-2015/ Health status has improved more in women than in men with rheumatoid arthritis from 1994 to 2009: results from the Oslo rheumatoid arthritis register https://icostatistics.no/publication/austad-health-2015/ Thu, 01 Jan 2015 00:00:00 +0000 https://icostatistics.no/publication/austad-health-2015/ Performance development in adolescent track and field athletes according to age, sex and sport discipline https://icostatistics.no/publication/tonnessen-performance-2015/ Thu, 01 Jan 2015 00:00:00 +0000 https://icostatistics.no/publication/tonnessen-performance-2015/ Uveitis is associated with hypertension and atherosclerosis in patients with ankylosing spondylitis: a cross-sectional study https://icostatistics.no/publication/berg-uveitis-2014/ Mon, 01 Dec 2014 00:00:00 +0000 https://icostatistics.no/publication/berg-uveitis-2014/ A large conditioned pain modulation response is not related to a large blood pressure response: a study in healthy men https://icostatistics.no/publication/nilsen-large-2014/ Wed, 01 Oct 2014 00:00:00 +0000 https://icostatistics.no/publication/nilsen-large-2014/ NOR-DMARD data management: implementation of data capture from electronic health records https://icostatistics.no/publication/olsen-nor-dmard-2014/ Wed, 01 Oct 2014 00:00:00 +0000 https://icostatistics.no/publication/olsen-nor-dmard-2014/ Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity https://icostatistics.no/publication/gandjbakhch-determining-2014/ Sat, 01 Feb 2014 00:00:00 +0000 https://icostatistics.no/publication/gandjbakhch-determining-2014/ Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot study https://icostatistics.no/publication/sveaas-efficacy-2014/ Wed, 01 Jan 2014 00:00:00 +0000 https://icostatistics.no/publication/sveaas-efficacy-2014/ Carotid plaque characteristics and disease activity in rheumatoid arthritis https://icostatistics.no/publication/semb-carotid-2013/ Mon, 01 Apr 2013 00:00:00 +0000 https://icostatistics.no/publication/semb-carotid-2013/ Associations between APOE genotypes and disease susceptibility, joint damage and lipid levels in patients with rheumatoid arthritis https://icostatistics.no/publication/maehlen-associations-2013/ Tue, 01 Jan 2013 00:00:00 +0000 https://icostatistics.no/publication/maehlen-associations-2013/ A 1-year randomized, double-blind, placebo-controlled study of intravenous ibandronate on bone loss following renal transplantation https://icostatistics.no/publication/smerud-1-year-2012/ Sat, 01 Dec 2012 00:00:00 +0000 https://icostatistics.no/publication/smerud-1-year-2012/ Consequences of handling missing data for treatment response in osteoarthritis: a simulation study https://icostatistics.no/publication/olsen-consequences-2012/ Wed, 01 Aug 2012 00:00:00 +0000 https://icostatistics.no/publication/olsen-consequences-2012/ ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial https://icostatistics.no/publication/torkildsen-3-2012/ Wed, 01 Aug 2012 00:00:00 +0000 https://icostatistics.no/publication/torkildsen-3-2012/ An approach to combining parallel and cross-over trials with and without run-in periods using individual patient data https://icostatistics.no/publication/tvete-approach-2012/ Sun, 01 Apr 2012 00:00:00 +0000 https://icostatistics.no/publication/tvete-approach-2012/ Effect of piboserod, a 5-HT4 serotonin receptor antagonist, on left ventricular function in patients with symptomatic heart failure https://icostatistics.no/publication/kjekshus-effect-2009/ Sat, 01 Aug 2009 00:00:00 +0000 https://icostatistics.no/publication/kjekshus-effect-2009/ NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial https://icostatistics.no/publication/sorensen-nordic-2009/ Mon, 01 Jun 2009 00:00:00 +0000 https://icostatistics.no/publication/sorensen-nordic-2009/ Effect of oxcarbazepine in the treatment of agitation and aggression in severe dementia https://icostatistics.no/publication/sommer-effect-2009/ Thu, 01 Jan 2009 00:00:00 +0000 https://icostatistics.no/publication/sommer-effect-2009/